1. Home
  2. GDDY vs BBIO Comparison

GDDY vs BBIO Comparison

Compare GDDY & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoDaddy Inc.

GDDY

GoDaddy Inc.

N/A

Current Price

$80.98

Market Cap

12.5B

Sector

Technology

ML Signal

N/A

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

N/A

Current Price

$68.03

Market Cap

15.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GDDY
BBIO
Founded
1997
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.5B
15.3B
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
GDDY
BBIO
Price
$80.98
$68.03
Analyst Decision
Buy
Strong Buy
Analyst Count
16
24
Target Price
$145.06
$83.00
AVG Volume (30 Days)
2.4M
2.8M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
6.22
N/A
Revenue
N/A
$502,076,000.00
Revenue This Year
$8.02
$88.86
Revenue Next Year
$6.08
$74.11
P/E Ratio
$13.91
N/A
Revenue Growth
N/A
126.26
52 Week Low
$73.06
$28.33
52 Week High
$193.55
$84.94

Technical Indicators

Market Signals
Indicator
GDDY
BBIO
Relative Strength Index (RSI) 34.97 47.47
Support Level $73.06 $61.95
Resistance Level $93.00 $68.71
Average True Range (ATR) 4.35 3.33
MACD 0.38 0.54
Stochastic Oscillator 38.29 44.46

Price Performance

Historical Comparison
GDDY
BBIO

About GDDY GoDaddy Inc.

GoDaddy Inc provides digital solutions and services for entrepreneurs, small businesses, individuals, organizations, developers, designers, and domain investors. It offers tools intended to support business creation and management through an integrated service platform. The company operates through two segments: Applications and Commerce (A&C) and Core Platform (Core). The majority of the company's revenue is derived from the Core Platform segment, which consists of sales of domain registrations and renewals, aftermarket domain sales, website hosting products and website security products. Geographically, it generates the maximum revenue from the United States.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: